国产99久久精品_欧美日本韩国一区二区_激情小说综合网_欧美一级二级视频_午夜av电影_日本久久精品视频

金豪制藥 
北京金豪制藥股份有限公司是從事生物技術領域的高新技術企業。1993年成立，公司位于北京經濟技術開發區，占地面積6000平方米，擁有標準的GMP生產廠房。2006年，公司通過了ISO13485：2003和ISO9001：2000體系認證，在生產質量管理方面邁上新臺階，大大提高了自身競爭力。公司本著銳意進取、求實創新的精神，重視基礎研究，自行研發了多項基因工程抗原和單克隆抗體，并相繼推出了酶聯免疫試劑、免疫快速診斷試劑、分子診斷試劑、血型試劑、生化試劑等產品，品種多達80余種。

隨著國際生物技術的快速發展，金豪公司始終保持走在生物技術領域的最前列，逐步成為該領域最具有影響力的企業；承擔著衛生部艾滋病確證試劑研制與開發的項目，以及國家生物反恐等重大科研項目；成功地建立了國內一流的集信息、科研、生產和銷售四位一體的操作平臺，先后與歐洲、北美、日本和澳大利亞等數十家相關企業和科研機構建立了廣泛的技術交流與合作，并與國內數百家血站，醫院和科研機構等單位保持良好的業務往來，企業實現了良好的增長。

公司本著“追求卓越 奉獻社會”的質量方針，建立多品種生產線，設定不同目標客戶群體，成為為客戶提供包括產品、服務、技術和方案的體外診斷試劑行業的領先者。實現從產品戰略到技術集成戰略的飛躍，通過引進或合作研發新技術進行資本運行，成為診斷試劑行業技術研發的先導者，加速企業價值的提升。

 Beijing kinghawk pharmaceutical co.,ltd.
Founded in 1993 and located in Beijing Economic and Technological Development Area, Beijing Kinghawk Pharmaceutical Co.,Ltd is a hi-tech enterprise which covers 6000m2 and possesses 2000m2 GMP workshops, and is ISO13485 certified by TUV in 2006 and GMP certified by SFDA in 2003, specialized in research, development and production of in-vitro diagnostic reagents in China.

Over a decade of development, KINGHAWK has been transformed into one of the leading IVD companies in China. Now, over 80 kinds of in-vitro diagnosis products of ELISA series, clinical chemistry reagents series, rapid detection series, PCR series and blood grouping series are manufactured and marked through out of China. With its systematic products and professional services, a good direct sale and service network and effective channels have been established around the country. KINGHAWK’s sincerely customers range in China CDC, large hospitals,blood stations, and scientific research institutes.

Besides, KINGHAWK has actively undertaken several state-level research projects such as AIDS confirmation reagent originated by Ministry of Health of the P.R.China and biological antiterrorism projects originated by the Academy of Military Medical Sciences. By cooperating with foreign enterprises in Europe, North America, Japan and Australia, KINGHAWK has set up extensive technical exchange channels with the new development of the Diagnostic industry and kept the same pace with global science and technology.